Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Method accurately measures finasteride concentration in medicine.

Ammonium bisulfite in hair bleach can cause facial eczema.

Amla oil may help treat hair loss.

The optimal mix of Dendropanax, sea salt, and other extracts can help reduce hair loss.

CMADK reduces hair damage from bleaching and permanent waving.

Hair properties change under electromagnetic fields and are influenced by individual characteristics and the environment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Epithelial-mesenchymal interactions control hair growth cycles through specific molecular signals.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Keratins are important for skin cell health and their problems can cause diseases.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Human liver cells stick to hair protein materials mainly through the liver's asialoglycoprotein receptor.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.